Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 June 2023 | Story Kamohelo Tshabalala | Photo Supplied
Dr  Kamohelo Tshabalala
Dr Kamohelo Tshabalala, Senior Lecturer in the Department of Physics, shares his UFS journey.

The University of the Free State (UFS) is celebrating Youth Month by showcasing the positive influence of the institution on career development. As part of this initiative, we are sharing the stories of UFS alumni who are now working at the university.

Dr Kamohelo Tshabalala, Senior Lecturer in the Department of Physics, shares his UFS journey:

Q: Year of graduation from the UFS: 

A: 2004 and 2015.

Q: Qualification obtained from the UFS: 

A: BSc in Physics and Mathematics and PhD in Solid State Physics.

Q: Date of joining the UFS as a staff member: 

A: 2003 to 2004 and 2012 to date.

Q: Initial job title and current job title: 

A: I began my journey as a Lab Assistant, but over time, I advanced to higher positions within the academic realm. Presently, I proudly serve as a Senior Lecturer and Subject Head in the esteemed Department of Physics. Additionally, I have taken on the role of acting Assistant Dean in the distinguished Faculty of Natural and Agricultural Sciences.

Q: How did the UFS prepare you for the professional world? 

A: First and foremost, I successfully completed my BSc degree, followed by the attainment of a Doctor of Philosophy (PhD). I firmly believe that these educational achievements serve as a solid foundation for excelling in both teaching and leadership roles.

Q: What are your thoughts on transitioning from a UFS alumnus to a staff member? 

A: It is a very interesting aspect; however, this transition may entirely depend on an individual’s interest in whether to continue with their studies or not. The stimulation may come from the undergraduate teachings that exhibit real interventions for new developments towards empowering the society at large.

Q: Any additional comments about your experience? 
A: As both an academic and a departmental leader for the past nine years, I am very grateful for all the support from the university community. I would encourage young scholars to explore more leadership roles that are available in the sector, because one is always up to date with new initiatives and strategies for the betterment of human and academic projects.

News Archive

#Women'sMonth: Save the children
2017-08-10

Description: Trudi O'Neill Tags: : rotaviruses, young children, Dr Trudi O’Neill, Department of Microbial, Biochemical and Food Biotechnology, vaccine 

Dr Trudi O’Neill, Senior lecturer in the Department of
Microbial, Biochemical and Food Biotechnology.
Photo: Anja Aucamp

Dr Trudi O’Neill, Senior lecturer in the Department of Microbial, Biochemical and Food Biotechnology, is conducting research on rotavirus vaccines.

Dr O’Neill was inspired to conduct research on this issue through her fascination with the virus. “The biology of rotaviruses, especially the genome structure and the virus’ interaction with the host, is fascinating.”

“In fact, it is estimated that, globally, ALL children will be infected with rotavirus before the age of five, irrespective of their socio-economic standing. However, infants and young children in poor countries are more vulnerable due to inadequate healthcare. The WHO estimates that approximately 215 000 deaths occur each year. This roughly equates to eight Airbus A380 planes, the largest commercial carrier with a capacity of approximately 500 seats, filled with only children under the age of five, crashing each week of every year.”

Alternative to expensive medicines 
“Currently, there are two vaccines that have been licensed for global use. However, these vaccines are expensive and poor countries, where the need is the greatest, are struggling to introduce them sustainably. It is therefore appealing to study rotaviruses, as it is scientifically challenging, but could at the same time have an impact on child health,” Dr O’Neill said.

The main focus of Dr O’Neill’s research is to develop a more affordable vaccine that can promote child vaccination in countries/areas that cannot afford the current vaccines.

All about a different approach 

When asked about the most profound finding of her research, Dr O’Neill responded: “It is not so much a finding, but rather the approach. My rotavirus research group is making use of yeast as vehicle to produce a sub-unit vaccine. These microbes are attractive, as they are relatively easy to manipulate and cheap to cultivate. Downstream production costs can therefore be reduced. The system we use was developed by my colleagues, Profs Koos Albertyn and Martie Smit, and allows for the potential use of any yeast. This enables us to screen a vast number of yeasts in order to identify the best yeast producer.”

Vaccination recently acquired a bad name in the media for its adverse side effects. As researcher, Dr O’Neill has this to say: “Vaccines save lives. By vaccinating your child, you don’t just protect your own child from a potentially deadly infection, but also other children in your community that might be too young to be vaccinated or have pre-existing health problems that prevents vaccination.” 

A future without rotavirus vaccination?

Dr O’Neill believes a future without rotavirus vaccination will be a major step backwards, as the impact of rotavirus vaccines has been profound. “Studies in Mexico and Malawi actually show a reduction in deaths. A colleague in Mozambique has commented on the empty hospital beds that amazed both clinicians and scientists only one year after the introduction of the vaccine in that country. Although many parents, mostly in developed countries, don’t have to fear dehydrating diarrhoea and potential hospitalisation of their babies due to rotavirus infection anymore, such an infection could still be a death sentence in countries that have not been able to introduce the vaccine in their national vaccination programmes,” she said. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept